Arbutus Biopharma Corp (ABUS) Total assets 2016–2025
Arbutus Biopharma Corp (ABUS) total assets at each fiscal year-end, per SEC filings.
$94.6MFY2025 · since FY2016: $275.9M → $94.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $94.6M | -28.2% |
| FY2024 | $131.7M | -8.8% |
| FY2023 | $144.4M | -26.1% |
| FY2022 | $195.4M | -4.4% |
| FY2021 | $204.5M | +49.2% |
| FY2020 | $137.1M | +29.9% |
| FY2019 | $105.5M | -53.7% |
| FY2018 | $227.9M | -3.9% |
| FY2017 | $237.2M | -14.0% |
| FY2016 | $275.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ABUS financial trends
ABUS RevenueABUS Net incomeABUS Net marginABUS Gross profitABUS Gross marginABUS Operating incomeABUS Operating marginABUS Operating cash flowABUS Free cash flowABUS Capital expendituresABUS Return on equityABUS Stock buybacksABUS Dividends paidABUS Total liabilitiesABUS Shareholders’ equityABUS overview →